newsfilter
← Latest News
GlobeNewswire·

Senti Bio Participates in Nasdaq Amplify Spotlight Series

Access the segment here SOUTH SAN FRANCISCO, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio" or the "Company"), a clinical-stage biotechnology company developing